Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Aimmune Therapeutics: (AIMT, $23.63) Palforzia for Peanut Allergy Desensitization Has the Potential to Be a Blockbuster

Introduction

Aimmune is the first company for some time on which I have picked up coverage. My screening criteria is not…
Read more…

New Approach to SmithOnStocks Reports Starts with Aimmune Therapeutics (AIMT, $18.73)

My coverage strategy has been to identify stocks that I believed to be buys and initiate coverage with an in-depth…
Read more…